Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European lacidipine study on atherosclerosis

Circulation

Volumn 126, Issue 5, 2012, Pages 569-578

  Mancia, Giuseppe ^a   Facchetti, Rita ^a   Parati, Gianfranco ^a   Zanchetti, Alberto ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

BP variability; carotid intima media thickness; hypertension; risk factors

Indexed keywords

ATENOLOL; LACIDIPINE;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR DISEASE; CAROTID ATHEROSCLEROSIS; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADRENERGIC ANTAGONISTS; AGED; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CIRCADIAN RHYTHM; DIHYDROPYRIDINES; DOUBLE-BLIND METHOD; EUROPE; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; OFFICE VISITS; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84864450634     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.107565     Document Type: Article

References (28)

1. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dalhöf B, Sever PS, Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure and episodic hypertension. Lancet. 2010;375:895-905.
2. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dalhöf B, Poulter NR, Sever PS; ASCOT-BPLA and MRC Trial Investigators. Effect of-blockers and calcium channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9: 469-480.
3. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive- drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010; 375:906-915.
4. Mancia G. Prognostic value of long-term blood pressure variability: the evidence is growing. Hypertension. 2011;57:141-143.
5. Zanchetti A. Wars, war games and dead bodies on the battle-field: variations on the theme of blood pressure variability. Stroke. 2011;42: 2722-2724.
6. Dalhö f B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366:895-906. (Pubitemid 41265663)
7. Medical Research Council trial of treatment of hypertension in older adults: principal results: MRC Working Party. BMJ. 1992;304: 405-412.
8. Mancia G, de Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Strujiker-Boudier HA, Zanchetti A. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25: 1105-1187. (Pubitemid 46924065)
9. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Strujiker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A. European Society of Hypertension reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009;27:2121-2158.
10. Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, Hansson L, Magnagni B, Rahn KH, Reid JL, Rodicio J, Safar M, Eckes L, Rizzini P; European Lacidipine Study on Atherosclerosis Investigators. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation. 2002;106:2422-2427. (Pubitemid 35278796)
11. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340:14-22. (Pubitemid 29024679)
12. Zanchetti A, Hennig M, Hollweck R, Bond G, Tang R, Cuspidi C, Parati G, Facchetti R, Mancia G. Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA). Circulation. 2009;120: 1084-1090.
13. O'Brien E, Petrie J, Littler W, de Swiet M, Padfield PL, Altman DG, Bland M, Coats A, Atkins N. An outline of the revised British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens. 1993;11:677-679. (Pubitemid 23225212)
14. O'Brien E, Atkins N, Stergiou G, Karpettas N, Parati G, Asmar R, Imai Y, Wang J, Mengden T, Shennan A; Working Group on Blood Pressure Monitoring of the European Society of Hypertension. European Society of Hypertension international protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit. 2010;15:23-38.
15. Zanchetti A, Bond MG, Hennig M, Tang R, Hollweck R, Mancia G, Eckes L, Micheli D; ELSA Investigators. Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens. 2004;22:1201-1212. (Pubitemid 38721012)
16. Tang R, Hennig M, Bond MG, Hollweck R, Mancia G, Zanchetti A. Quality control of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis. J Hypertens. 2005;23:1047-1054. (Pubitemid 40637924)
17. Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment. J Hypertens. 2012;30:1241-1251.
18. Mancia G, Messerli F, Bakris G, Zhou O, Champion A, Pepine CJ. Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril Study. Hypertension. 2007;50:299-305. (Pubitemid 47205777)
19. Mancia G, Schumacher H, Redon J, Verdecchia P, Schmieder R, Jennings G, Yusoff K, Ryden, L Lisheng L, Teo K, Sleight P, Yusuf S. Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the ONTARGET trial. Circulation. 2011;124:1727-1736.
20. Mancia G, Parati G, Hennig M, Flatan B, Omboni S, Glavina F, Costa B, Scherz R, Bond G, Zanchetti A; ELSA investigators. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens. 2001;19:1981-1989. (Pubitemid 33035803)
21. Clement DL, De Buyzere ML, De Bacquer DA, De Leeuw PW, Duprez DA, Fagard R, Gheeraert PJ, Missault L, Braun JJ, Six RO, Van Der Niepen P, O'Brien E; Office Versus Ambulatory Pressure Study Investigators. Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348:2407-2415. (Pubitemid 36682819)
22. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomiletho J, Webster J. Predicting cardiovascular risk using conventional vs ambulatory blood pressure patients with systolic hypertension: Systolic Hypertension in Europe Trial Investigators. JAMA. 1999;282:539-546. (Pubitemid 29380290)
23. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777-1783. (Pubitemid 40525142)
24. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen J, O'Brien E. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin Outcome Study. Hypertension. 2005;46:156-161. (Pubitemid 40946507)
25. Franklin SS, Larson MG, Kahn SA, Wong ND, Leip EP, Kannel WB, Levy D. Does relations of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation. 2001; 103:1245-1249. (Pubitemid 32221347)
26. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, Coope J, Ekbom T, Gueyffier F, Liu L, Kerlikowske K, Pocock S, Fagard RH. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials erratum in Lancet. 2001; 357:724. Lancet. 2000;355:865-872. (Pubitemid 30137665)
27. Costanzo P, Perrone-Filardi P, Vassallo E, Paolillo S, Cesarano P, Brevetti G, Chiariello M. Does carotid intima-media thickness regression predict reduction of cardiovascular events? J Am Coll Cardiol. 2010;56: 2006-2020.
28. Goldberger Z, Valle J, Dandekar VK, Chan PS, Ko DT, Nallamothu BK. Area changes in carotid intima-media thickness related to risk of nonfatal myocardial infarction? A critical review and meta-regression analysis. Am Heart J. 2010;160:701-714.